Medjet
This article was originally published in The Gray Sheet
Executive Summary
Strategic alternatives under consideration by the ophthalmic device maker include sale of the company, one or more joint ventures, a merger or restructuring. Edison, New Jersey-based Medjet's first commercial product, the HydroBrush water jet-based keratome for ophthalmic epithelium removal, was 510(k) cleared in January 1998 (1"The Gray Sheet" Feb. 16, 1998, I&W-8). A new water jet microkeratome under development "is working well, and its advantages for use in refractive surgery have been evident to surgeons that have used it," Chairman Eugene Gordon says in a release. "We believe that exploring strategic options may hasten its introduction and help Medjet's common stock to more accurately reflect the quality of its technology"